Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>During cutting cycles, <strong>Dragon Pharma Cagrilintide</strong> is administered subcutaneously to aid in calorie control. Users typically start at a low dose of 0.3 mg per week and gradually increase to 1.2 mg per week over a 12–16 week cycle. This peptide is commonly stacked with <a href="https://www.dragonpharma.net/orals-380/anavar-2866">Anavar</a>, <a href="https://www.dragonpharma.net/peptides-414/dragontropin-46298">HGH</a>, or <a href="https://www.dragonpharma.net/fat-loss-397/clenbuterol-3166">Clenbuterol</a> to accelerate fat loss while maintaining strength and lean muscle mass.</p>
<p>Users sourcing fat-loss stacks often trust only established platforms. As part of the <a href="/">trusted Dragon Pharma supplier</a> network, our store guarantees pharmaceutical-grade peptides shipped directly to your door.</p>
<h3>Example Cagrilintide Cycle Protocol</h3>
<ul>
<li><strong>Weeks 1–4:</strong> 0.3 mg per week (subcutaneous, 1–2x weekly)</li>
<li><strong>Weeks 5–12:</strong> Gradually increase to 1.2 mg/week based on tolerance</li>
<li>Stack with Clenbuterol or HGH for enhanced metabolic support</li>
</ul>
<p>Clinical studies have investigated the role of amylin analogs like Cagrilintide in appetite regulation and metabolic control, supporting its use in fat-loss and glucose management protocols. <a href="https://pubmed.ncbi.nlm.nih.gov/?term=cagrilintide+amylin+analog" rel="noopener" target="_blank">See related studies on PubMed</a>.</p>
<h3>Potential Side Effects</h3>
<p>Initial side effects may include mild nausea, bloating, or appetite fluctuations—usually subsiding after a few days. Less common effects include lightheadedness or gastrointestinal discomfort. Users should avoid stacking with glucose-lowering drugs without supervision.</p>
<p>For most, Cagrilintide offers excellent tolerability and becomes an effective aid in long-term fat loss management when paired with diet and training consistency.</p>
</section>
</div>
Technical Details
Peptide Type
Long-Acting Amylin Analogue
Peptide Sequence
XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP
Peptide Length
38 Amino-Acid Residues
Structural Features
Lipidated & Disulfide-Cyclized
Molecular Formula
C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight
4409 g/mol
Receptor Class
Calcitonin-Family Receptors
Development Status
Investigational